| Title |
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, May 2011
|
| DOI | 10.1007/s00262-011-1023-5 |
| Pubmed ID | |
| Authors |
Christian Bauer, Marc Dauer, Samira Saraj, Maximilian Schnurr, Franz Bauernfeind, Alexander Sterzik, Jana Junkmann, Veronika Jakl, Rosemarie Kiefl, Fuat Oduncu, Bertold Emmerich, Doris Mayr, Thomas Mussack, Christiane Bruns, Dominik Rüttinger, Claudius Conrad, Karl-Walter Jauch, Stefan Endres, Andreas Eigler |
| Abstract |
Dendritic cell (DC)-based vaccination can induce antitumor T cell responses in vivo. This clinical pilot study examined feasibility and outcome of DC-based tumor vaccination for patients with advanced pancreatic adenocarcinoma. |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Unknown | 41 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 26% |
| Student > Bachelor | 4 | 10% |
| Student > Master | 4 | 10% |
| Student > Doctoral Student | 3 | 7% |
| Other | 3 | 7% |
| Other | 7 | 17% |
| Unknown | 10 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 10 | 24% |
| Medicine and Dentistry | 8 | 19% |
| Immunology and Microbiology | 7 | 17% |
| Biochemistry, Genetics and Molecular Biology | 4 | 10% |
| Unspecified | 1 | 2% |
| Other | 2 | 5% |
| Unknown | 10 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2023.
All research outputs
#3,625,854
of 24,535,155 outputs
Outputs from Cancer Immunology, Immunotherapy
#255
of 2,914 outputs
Outputs of similar age
#16,828
of 114,545 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 31 outputs
Altmetric has tracked 24,535,155 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,914 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 114,545 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.